Phosphorylcholine antibodies restrict infarct size and left ventricular remodelling by attenuating the unreperfused post-ischaemic inflammatory response.

J Cell Mol Med · 2021 · PMC8358891 · PMID 34190404

Europe PMC DOI

hedged sentence

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

a strong trendP = .067so close (0.05 < p ≤ 0.1)

3.5 PC‐mAb reduces LV fibrous content and ameliorates wall thickness Three weeks following unreperfused MI, PC‐mAb treatment showed a strong trend towards a decreased LV fibrous content compared to vehicle treatment (18.6% ± 1.4% vs 25.5% ± 3.4%, P = .067; Figure 4A ), confirming our results obtained with contrast‐enhanced CMR imaging.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.